Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification

[1]  T. Komori.  Updated 2016 WHO classification of tumors of the CNS: turning the corner where molecule meets pathology , 2017, Brain Tumor Pathology.

[2]  T. Komori,et al.  The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision , 2017, Neurologia medico-chirurgica.

[3]  Satoshi O. Suzuki,et al.  A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology , 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.

[4]  Susan M. Chang,et al.  A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics , 2017, Neuro-oncology.

[5]  Satoshi O. Suzuki,et al.  Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution , 2017, Brain Tumor Pathology.

[6]  Satoshi O. Suzuki,et al.  Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade , 2016, OncoTargets and therapy.

[7]  Satoshi O. Suzuki,et al.  Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data , 2016, PloS one.

[8]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[9]  Adelheid Woehrer,et al.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment. , 2015, CNS oncology.

[10]  Alexander R. Pico,et al.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.

[11]  Satoru Miyano,et al.  Mutational landscape and clonal architecture in grade II and III gliomas , 2015, Nature Genetics.

[12]  R. Sanyal,et al.  Outcomes, complications, and costs of care of Bosniak IIF, III, and IV cystic renal lesions/malignancies: Data from the largest multi-institutional study to date. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Winand N M Dinjens,et al.  Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Shaw,et al.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Mizoguchi,et al.  Loss of heterozygosity analysis in malignant gliomas , 2011, Brain Tumor Pathology.

[16]  C. Langford,et al.  Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses. , 2010, Neuro-oncology.

[17]  G. Reifenberger,et al.  NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Iafrate,et al.  Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss , 2009, Clinical Cancer Research.

[19]  Satoshi O. Suzuki,et al.  Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues. , 2008, Neuro-oncology.

[20]  M. Fukui,et al.  Multiplexed Analysis of Post‐PCR Fluorescence‐labeled Microsatellite Alleles and Statistical Evaluation of Their Imbalance in Brain Tumors , 2002, Japanese journal of cancer research : Gann.

[21]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.